Alphatec Holdings Inc  

(Public, NASDAQ:ATEC)   Watch this stock  
Find more results for Mortimer Berkowitz, III
-0.01 (-0.74%)
May 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.35 - 1.40
52 week 1.23 - 1.92
Open 1.35
Vol / Avg. 27,215.00/87,210.00
Mkt cap 134.79M
P/E     -
Div/yield     -
EPS -0.11
Shares 99.85M
Beta 1.64
Inst. own 62%
Jul 29, 2015
Q2 2015 Alphatec Holdings Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 26, 2015
Alphatec Holdings Inc Annual Shareholders Meeting (Estimated) - 5:00AM EDT - Add to calendar
Jun 3, 2015
Alphatec Holdings Inc at Jefferies Global Healthcare Conference - 11:00AM EDT - Add to calendar
May 19, 2015
Alphatec Holdings Inc at UBS Global Healthcare Conference
Apr 30, 2015
Q1 2015 Alphatec Holdings Inc Earnings Call - Webcast
Apr 30, 2015
Q1 2015 Alphatec Holdings Inc Earnings Release
Mar 24, 2015
Alphatec Holdings Inc at Canaccord Genuity Musculoskeletal Conference
Mar 4, 2015
Alphatec Holdings Inc at Cowen Health Care Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -9.38% -6.22%
Operating margin 2.35% 0.89%
EBITD margin - 10.12%
Return on average assets -5.50% -3.63%
Return on average equity -12.91% -8.04%
Employees 450 -
CDP Score - -


5818 El Camino Real
United States - Map
+1-760-4319286 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Alphatec Holdings, Inc., is a medical technology company. The Company is enganged in the design, development, manufacturing and marketing of products for surgical treatment of spine disorders. The Company has product portfolio and pipelines that addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a variety of spinal disorders and procedures. The Company's principal product offerings are focused on the global market for orthopedic spinal disorder solutions. The Company's product offering includes a variety of spinal implant products and systems consisted of components, like spine screws and rods, spinal spacers, plates, and biologics offerings. In addition, outside of the United States, the Company sells solutions for treating vertebral compression fractures and spinal stenosis. The Company’s principal products include Cervical and Cervico-thoracic products, Thoracolumbar products, Spinal Spacers, Minimally Invasive Surgery products and Biologics.

Officers and directors

James M. Corbett President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Michael O'Neill Chief Financial Officer, Vice President, Treasurer
Age: 55
Bio & Compensation  - Reuters
Mitsuo Asai President of Alphatec Pacific, Inc.
Age: 60
Bio & Compensation  - Reuters
Michael Plunkett Chief Operating Officer
Age: 57
Bio & Compensation  - Reuters
Ebun S. Garner Esq. Senior Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Mark Bullivant Senior Vice President - International
Age: 46
Bio & Compensation  - Reuters
Kristin Machacek Leary Senior Vice President - Global Human Resources
Age: 46
Bio & Compensation  - Reuters
Stephen A. Lubischer Vice President - Sales
Age: 52
Bio & Compensation  - Reuters
Leslie H. Cross Non-Executive Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Mortimer Berkowitz III Director
Age: 61
Bio & Compensation  - Reuters